"metastatic cancer" trang 14 - tải miễn phí từ tailieuXANH
Nivolumab plus ipilimumab versus nivolumab in individuals with treatmentnaive programmed death-ligand 1 positive metastatic soft tissue sarcomas: A multicentre retrospective study

Nivolumab plus ipilimumab versus nivolumab in individuals with treatmentnaive programmed death-ligand 1 positive metastatic soft tissue sarcomas: A multicentre retrospective study
8    47    1
CABOCOL-01 trial: A single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure

CABOCOL-01 trial: A single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
12    170    1
The DANTE trial protocol: A randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

The DANTE trial protocol: A randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
10    224    1
Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: A retrospective comparative study

Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: A retrospective comparative study
8    38    1
The role of liver resection in metastatic nephroblastoma: A systematic review and Meta-regression analysis

The role of liver resection in metastatic nephroblastoma: A systematic review and Meta-regression analysis
16    86    3
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologicallyselected advanced colorectal cancer patients: The CIFRA study protocol

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologicallyselected advanced colorectal cancer patients: The CIFRA study protocol
9    47    0
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
9    80    0
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: Results of a randomized study - SAKK 22/99

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: Results of a randomized study - SAKK 22/99
9    64    0
Cetuximab for esophageal cancer: An updated meta-analysis of randomized controlled trials

Cetuximab for esophageal cancer: An updated meta-analysis of randomized controlled trials
13    106    0
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer

Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer
8    43    0
Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer
11    52    0
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer

Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer
6    49    0
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nabpaclitaxel therapy in metastatic pancreatic cancer

Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nabpaclitaxel therapy in metastatic pancreatic cancer
9    67    0
Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer
8    31    0
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine

A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine
16    47    0
Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling

Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
14    47    0
High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer

High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
9    53    0
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: A pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: A pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
9    52    0
An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion

An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion
8    103    0
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study
9    44    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.